Bristol-Myers Squibb Co. Logo

Bristol-Myers Squibb Co. (BMY)

BCBA

Currency in ARS
35,800.00
+180.00 (+0.51%)

Real-time Data

02:00 PM

Day's Range

35,480.00
35,860.00

52 wk Range

19,980.00
36,060.00

Analyst Ratings - BMY - Bristol-Myers Squibb Co.

Analyst ratings

DateFirmActionRating
Nov 15, 2024Wolfe ResearchInitiates coveragePeer Perform
Oct 27, 2023William BlairDowngradeOutperform → Market Perform
Jul 20, 2023Cantor FitzgeraldMaintainsOverweight
Jul 19, 2023Morgan StanleyReiteratesUnderweight
Jul 14, 2023HSBCInitiates coverageReduce
Apr 21, 2023B of A SecuritiesMaintainsBuy
Oct 10, 2022GuggenheimDowngradeBuy → Neutral
Jun 06, 2022Raymond JamesDowngradeOutperform → Market Perform
Jun 03, 2022Raymond JamesDowngradeOutperform → Market Perform
Dec 17, 2021Goldman SachsInitiates coverageBuy
Items per row:

Estimates - BMY - Bristol-Myers Squibb Co.

Estimate momentum

Current quarter · How the consensus estimate has moved over the last 90 days.

Revised last month0/0

EPS estimates

PeriodAnalystsLowAverageHighYear ago
Current quarter-----
Next quarter-----
Current year-----
Next year-----

Earnings History - BMY - Bristol-Myers Squibb Co.

Estimate surprises

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-10-28-----
2026-07-29-----
2026-04-29-----
2026-04-21-----
2026-03-05-0.670.57-0.10‪-14.93%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.